The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 360 results:
Author Title Type [ Year(Asc)]
Filters: Author is Polyzos, Stergios A  [Clear All Filters]
2018
Doulberis, M., Kotronis G., Thomann R., Polyzos S. A., Boziki M., Gialamprinou D., et al. (2018).  Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?. Helicobacter. 23(1), 
Polyzos, S. A., & Margioris A. N. (2018).  Sarcopenic obesity.. Hormones (Athens). 17(3), 321-331.
Polyzos, S. A., & Mantzoros C. S. (2018).  Sixty-six years of Metabolism, Clinical and Experimental: The journey of a journal and opportunities and challenges looking ahead.. Metabolism. 78, A4-A9.
Anastasilakis, A. D., Polyzos S. A., & Makras P. (2018).  THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis.. Eur J Endocrinol. 179(1), R31-R45.
Efstathiadou, Z. A., Kita M. D., & Polyzos S. A. (2018).  Thyroid dysfunction and non-alcoholic fatty liver disease.. Minerva Endocrinol. 43(3), 367-376.
2017
Kountouras, J., Kapetanakis N., Polyzos S. A., Katsinelos P., Gavalas E., Tzivras D., et al. (2017).  Active Infection Is a Risk Factor for Colorectal Mucosa: Early and Advanced Colonic Neoplasm Sequence.. Gut Liver. 11(5), 733-734.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2017).  Adipose tissue, obesity and non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 92-108.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.. Int J Cardiol. 229, 17-18.
Anastasilakis, A. D., Koulaxis D., Kefala N., Polyzos S. A., Upadhyay J., Pagkalidou E., et al. (2017).  Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD. Metabolism. 73, 1-8.
Anastasilakis, A. D., Polyzos S. A., Makras P., Aubry-Rozier B., Kaouri S., & Lamy O. (2017).  Clinical Features of 24 Patients With Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Systematic Review and Additional Cases.. J Bone Miner Res. 32(6), 1291-1296.
Kazakos, E. I., Dorrell N., Polyzos S. A., Deretzi G., & Kountouras J. (2017).  Comment on "Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics".. World J Gastroenterol. 23(33), 6194-6196.
Polyzos, S. A., Kountouras J., Mantzoros C. S., Polymerou V., & Katsinelos P. (2017).  Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial.. Diabetes Obes Metab. 19(12), 1805-1809.
Polyzos, S. A. (2017).  Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver disease.. Minerva Endocrinol. 42(2), 89-91.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?. Int J Cardiol. 233, 92.
Kountouras, J., Polyzos S. A., Katsinelos P., Tzivras D., Boziki M., Gavalas E., et al. (2017).  Helicobacter pylori on portal hypertension-related hepatic encephalopathy.. Immunopharmacol Immunotoxicol. 39(2), 105-106.
Kountouras, J., Polyzos S. A., Zeglinas C., & Katsinelos P. (2017).  Helicobacter pylori-related chronic hepatitis C infection and the risk for cardiovascular disease.. Liver Int. 37(7), 1082.
Kountouras, J., Polyzos S. A., Zeglinas C., Tzathas C., Nikolaidis N., Vardaka E., et al. (2017).  Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort.. Gastrointest Endosc. 85(2), 462-463.
Kountouras, J., Boziki M., Polyzos S. A., Katsinelos P., Gavalas E., Zeglinas C., et al. (2017).  Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis.. Free Radic Res. 51(1), 73-79.
Polyzos, S. A., Duntas L., & Bollerslev J. (2017).  The intriguing connections of leptin to hyperparathyroidism.. Endocrine. 57(3), 376-387.
Polyzos, S. A., & Mantzoros C. S. (2017).  Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications.. Metabolism. 72, A4-A10.
Anastasilakis, A. D., Polyzos S. A., Tsoli M., Papatheodorou A., Kokkoris P., Kaltsas G., et al. (2017).  Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity.. Metabolism. 71, 198-201.
Polyzos, S. A., Bugianesi E., Kountouras J., & Mantzoros C. S. (2017).  Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists.. Metabolism. 66, 64-68.
Kazakos, E. I., Kountouras J., Polyzos S. A., & Deretzi G. (2017).  Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system.. Med Hypotheses. 102, 33-36.
Kountouras, J., Polyzos S. A., Katsinelos P., Kotronis G., & Doulberis M. (2017).  Obesity and the nervous system: more questions.. Lancet Neurol. 16(10), 772-773.
Polyzos, S. A., Makras P., Anastasilakis A. D., Mintziori G., Kita M., Papatheodorou A., et al. (2017).  Periostin and sclerostin levels in juvenile Paget's disease.. Clin Cases Miner Bone Metab. 14(2), 269-271.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.